NRSN
#4562
NeuroSense Therapeutics Ltd. - Ordinary Shares
0.7 2 USD
-0.01%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
-1.37%
Monatliche Änderung
+2.86%
6 month change
-18.18%
Jahresänderung
-64.53%
Vorheriger Schlusskurs
0.7 3
Open
0.7 2
Tief
0.7 2
High
0.7 2
Volumen
1
Financials
- Market Capitalization 23.44 M
- Employee 16
- Founded 2017
- CEO N/A
- Website www.neurosense-tx.com
- Headquarter Israel
- FIGI UNKNOWN
- Industry Biotechnologie
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 4556 |  NXTC NextCure, Inc. - Common Stock | 6.63 USD | +0.76% | +285.47% | +221.84% | -49.39% | 23.95 M USD | ||
| 4560 |  MRKR Marker Therapeutics, Inc. - Common Stock | 1.41 USD | -2.08% | -11.32% | +4.44% | -20.79% | 23.51 M USD | ||
| 4577 |  CELU Celularity Inc. - Class A Common Stock | 0.78 USD | +2.63% | +2.63% | +5.41% | -63.89% | 22.58 M USD | ||
| 4587 |  KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.44 USD | -0.22% | +2.60% | -6.01% | +129.74% | 21.76 M USD |